| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2189 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1625 | 2018 |
| Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial HLA Janssen, M van Zonneveld, H Senturk, S Zeuzem, US Akarca, ... The Lancet 365 (9454), 123-129, 2005 | 1588 | 2005 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 574 | 2014 |
| Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b EHCJ Buster, HJ Flink, Y Cakaloglu, K Simon, J Trojan, F Tabak, TMK So, ... Gastroenterology 135 (2), 459-467, 2008 | 529 | 2008 |
| Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. AS Lok, U Akarca, S Greene Proceedings of the National Academy of Sciences 91 (9), 4077-4081, 1994 | 508 | 1994 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 438 | 2022 |
| Novel hybridization indicator methylene blue for the electrochemical detection of short DNA sequences related to the hepatitis B virus A Erdem, K Kerman, B Meric, US Akarca, M Ozsoz Analytica Chimica Acta 422 (2), 139-149, 2000 | 432 | 2000 |
| Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study N Tozun, O Ozdogan, Y Cakaloglu, R Idilman, Z Karasu, U Akarca, ... Clinical Microbiology and Infection 21 (11), 1020-1026, 2015 | 423 | 2015 |
| Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease YF Liaw, IS Sheen, CM Lee, US Akarca, GV Papatheodoridis, ... Hepatology 53 (1), 62-72, 2011 | 421 | 2011 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 416 | 2014 |
| Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels V Rijckborst, BE Hansen, Y Cakaloglu, P Ferenci, F Tabak, M Akdogan, ... Hepatology 52 (2), 454-461, 2010 | 341 | 2010 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 278 | 2014 |
| Electrochemical DNA biosensor for the detection of TT and Hepatitis B virus from PCR amplified real samples by using methylene blue B Meric, K Kerman, D Ozkan, P Kara, S Erensoy, US Akarca, M Mascini, ... Talanta 56 (5), 837-846, 2002 | 210 | 2002 |
| Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos (t) ide-naive patients with chronic hepatitis B AS Lok, H Trinh, G Carosi, US Akarca, A Gadano, F Habersetzer, ... Gastroenterology 143 (3), 619-628. e1, 2012 | 191 | 2012 |
| Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial H Wedemeyer, C Yurdaydin, S Hardtke, FA Caruntu, MG Curescu, ... The Lancet infectious diseases 19 (3), 275-286, 2019 | 187 | 2019 |
| Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants D FitzSimons, G François, A Hall, B McMahon, A Meheus, A Zanetti, ... Vaccine 23 (32), 4158-4166, 2005 | 187 | 2005 |
| DNA electrochemical biosensor for the detection of short DNA sequences related to the hepatitis B virus A Erdem, K Kerman, B Meric, US Akarca, M Ozsoz Electroanalysis: An International Journal Devoted to Fundamental and …, 1999 | 174 | 1999 |
| Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease Z Omer, S Cetinkalp, M Akyildiz, F Yilmaz, Y Batur, C Yilmaz, U Akarca European journal of gastroenterology & hepatology 22 (1), 18-23, 2010 | 163 | 2010 |
| Naturally occurring hepatitis B virus core gene mutations US Akarca, ASF Lok Hepatology 22 (1), 50-60, 1995 | 147 | 1995 |
